Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TRAF3IP2 encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. Additionally we are shipping TRAF3IP2 Proteins (3) and many more products for this protein.
Showing 10 out of 117 products:
Human Polyclonal TRAF3IP2 Primary Antibody for WB - ABIN2472995
Leonardi, Chariot, Claudio, Cunningham, Siebenlist: CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. in Proceedings of the National Academy of Sciences of the United States of America 2000
Both the ACT-1 assay and the MAdCAM-1 (show MADCAM1 Antibodies) assay demonstrated acceptable reproducibility and repeatability. The assays were sufficiently stable to allow for clinical use. During clinical testing the assays demonstrated that vedolizumab was able to saturate peripheral cells at all doses tested.
A G/G genotype of rs766748 in IL-17F (show IL17F Antibodies), and a C/C or C/A genotype of rs1883136 in TRAF3IP2.
The suppressive effects of miR (show MLXIP Antibodies)-30a were mediated by directly targeting Traf3ip2 mRNA
TRAF3IP2 may play a causal role in aldosterone-induced adverse cardiac remodeling in vivo.
Single nucleotide polymorphisms in RBPJ (show RBPJ Antibodies), IL1R1 (show IL1RN Antibodies), REV3L (show REV3L Antibodies), TRAF3IP2, IRF1 (show IRF1 Antibodies) and ICOS (show CTLA4 Antibodies) showed association with rheumatoid arthritis in black South Africans.
A variant (rs76228616 SNP) in TRAF3IP2 gene could be involved in susceptibility to Steven-Johnson Syndrome.
identify Syk (show SYK Antibodies) as an upstream signaling molecule in IL-17A (show IL17A Antibodies)-induced Act1-TRAF6 (show TRAF6 Antibodies) interaction in keratinocytes, and inhibition of Syk (show SYK Antibodies) can attenuate CCL20 (show CCL20 Antibodies) production
These results indicate that oxLDL-induced endothelial cell death and dysfunction are mediated via TRAF3IP2 and that native HDL3 and the AMPK (show PRKAA1 Antibodies) activators inhibit this response.
Replicate the association of TRAF3IP2-_rs33980500 variant with the susceptibility to psoriasis.
this study demonstrated that although ACT1-v2-D10N is nonfunctional, ACT1-v1-D19N retains the ability to interact with Hsp90 (show HSP90 Antibodies) and is fully responsive to IL-17A (show IL17A Antibodies) stimulation.
using massively parallel reporter assays, we dissect the enhancer activity of three liver eExons (SORL1 (show SORL1 Antibodies) exon 17, TRAF3IP2 exon 2, PPARG (show PPARG Antibodies) exon 6) at single nucleotide resolution in the mouse liver
TRAF3IP2 is a critical intermediate in IL-18 (show IL18 Antibodies)-induced cardiac fibroblast migration and differentiation in vitro.
Our results support the important role of Act1 in the regulation of self-reactive B cells and reveal how Act1 functions to prevent the production of autoantibodies.
These results demonstrate for the first time that AOPPs induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent
CIKS knockdown inhibited high glucose-induced IKKbeta (show IKBKB Antibodies) and JNK (show MAPK8 Antibodies) phosphorylation, p65 (show NFkBP65 Antibodies) and c-Jun (show JUN Antibodies) nuclear translocation, and NF-kappaB (show NFKB1 Antibodies)- and AP-1 (show JUN Antibodies)-dependent proinflammatory cytokine, chemokine (show CCL1 Antibodies), and adhesion molecule (show NCAM1 Antibodies) expression.
The findings define a new role for the IKK-related kinases in suppressing IL-17-mediated NF-kappaB activation through TRAF6-dependent Act1 phosphorylation.
Data show that deletion of the CC' loop from Act1 or IL-17RA (show IL17RA Antibodies) abolished the interaction between both proteins.
our findings indicate that Act1 expression in T cells is required for cellular and humoral Th2-mediated allergic responses and the development of airway hyperresponsiveness
IL-17 (show IL17A Antibodies)-induced NF-kappaB (show NFKB1 Antibodies) activation via CIKS/Act1: physiologic significance and signaling mechanisms.
Study demonstrates that the TRAF3IP2 protein plays an important role in AD and suggests the protein as a therapeutic target to treat AD.
This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene.
adapter protein CIKS
, TRAF3 interacting protein 2
, adapter protein CIKS-like
, NFkB-activating protein ACT1
, connection to IKK and SAPK/JNK
, nuclear factor NF-kappa-B activator 1